Company Analysis

Serina Therapeutics, Inc. (SER)

NYSE: SER · Pharmaceutical Preparations · Huntsville, AL · filing with the SEC since 2017
Grade4.4
◀ Past 5.1● Present 2.0▶ Future 6.0
1 est.

Who runs Serina Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Ledger Steven A
Chief Executive Officer. First filing Apr 2024, latest May 27, 2026, 0 filings in all.
Officers reporting now
4
of 11 people with a filing in the last fifteen months
Directors reporting now
7
29 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Ledger Steven AChief Executive OfficerApr 2024May 27, 2026none
Curhan Gregory SChief Financial OfficerAug 2024May 26, 2026none
Moreadith RandallChief Scientific OfficerApr 2024May 26, 202629 · $500,000
Tenjarla SriniSVP, CMC & FormulationJul 2024May 26, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Simon FarrelldirectorJul 2026Jul 23, 2026none
Brannan Stephen K.directorJun 2025Jul 9, 2026none
Bailey GregorydirectorNov 2018Jun 22, 2026none
Marshall Richard PeterdirectorApr 2024Jun 22, 2026none
Venkatesan JaydirectorFeb 2025Jun 22, 2026none
Wilson Karen JdirectorJan 2025Jun 22, 2026none
Gill SimbadirectorApr 2024Feb 17, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SER · research, not advice